Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Noise exposure of workers and the use of hearing protection equipment in New Zealand.

John GW, Grynevych A, Welch D, McBride D, Thorne PR.

Arch Environ Occup Health. 2014;69(2):69-80. doi: 10.1080/19338244.2012.732122.

PMID:
24205958
2.

A validated model of calf compression and deep vessel collapse during external cuff inflation.

Narracott AJ, John GW, Morris RJ, Woodcock JP, Hose DR, Lawford PV.

IEEE Trans Biomed Eng. 2009 Feb;56(2):273-80. doi: 10.1109/TBME.2008.2005964. Epub 2008 Oct 3.

PMID:
19272917
3.

Influence of intermittent compression cuff design on calf deformation: computational results.

Narracott AJ, John GW, Hose DR, Morris RJ, Woodcock JP, Lawford PV.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:6334-8.

PMID:
18003470
4.

Influence of intermittent compression cuff design on interface pressure and calf deformation: experimental results.

John GW, Narracott AJ, Morris RJ, Woodcock JP, Lawford PV, Hose DR.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:2122-5.

PMID:
18002407
5.
6.

Treatment of Aphthous Stomatitis with topical Alchemilla vulgaris in glycerine.

Shrivastava R, John GW.

Clin Drug Investig. 2006;26(10):567-73.

PMID:
17163290
7.

Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.

Shrivastava R, Pechadre JC, John GW.

Clin Drug Investig. 2006;26(5):287-96.

PMID:
17163262
8.
9.

Cardioprotection of cariporide evaluated by plasma myoglobin and troponin I in myocardial infarction in pigs.

Létienne R, Bel L, Bessac AM, Denais D, Degryse AD, John GW, Le Grand B.

Fundam Clin Pharmacol. 2006 Apr;20(2):105-13.

PMID:
16573710
10.

Donitriptan decreases jugular venous oxygen saturation in rats in the absence of cranial vasoconstriction: an overlooked mechanism of antimigraine action?

Létienne R, Blanchet JC, Sole E, John GW, Le Grand B.

J Pharmacol Exp Ther. 2005 Nov;315(2):849-57. Epub 2005 Jul 18.

PMID:
16027226
11.

KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties.

John GW, Létienne R, Le Grand B, Pignier C, Vacher B, Patoiseau JF, Colpaert FC, Coulombe A.

Cardiovasc Drug Rev. 2004 Spring;22(1):17-26. Review.

PMID:
14978516
12.

Study of the interaction of lubeluzole with cardiac sodium channels.

Le Grand B, Talmant JM, Rieu JP, Patoiseau JF, John GW.

J Cardiovasc Pharmacol. 2003 Nov;42(5):581-7.

PMID:
14576504
14.

Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig: further insights into its mechanism of action relevant to headache relief.

Letienne R, Verscheure Y, Perez M, Le Grand B, Colpaert FC, John GW.

J Pharmacol Exp Ther. 2003 May;305(2):749-54. Epub 2003 Feb 11.

PMID:
12606602
15.

Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: implications for ischemic sodium loading.

Pinet C, Le Grand B, John GW, Coulombe A.

Circulation. 2002 Oct 15;106(16):2098-103.

PMID:
12379580
16.

Anti-ischemic compound KC 12291 prevents diastolic contracture in isolated atria by blockade of voltage-gated sodium channels.

Tamareille S, Le Grand B, John GW, Feuvray D, Coulombe A.

J Cardiovasc Pharmacol. 2002 Sep;40(3):346-55.

PMID:
12198320
17.

Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.

van den Broek RW, MaassenVanDenBrink A, Mulder PG, Bogers AJ, Avezaat CJ, John GW, Saxena PR.

Eur J Pharmacol. 2002 May 17;443(1-3):125-32.

PMID:
12044802
18.

Effects of donitriptan on carotid haemodynamics and cardiac output distribution in anaesthetized pigs.

Tom B, De Vries P, Heiligers JP, Willems EW, Kapoor K, John GW, Saxena PR.

Cephalalgia. 2002 Feb;22(1):37-47.

PMID:
11993612
19.

Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular system.

Létienne R, Vié B, Puech A, Vieu S, Le Grand B, John GW.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Apr;363(4):464-71.

PMID:
11330341
20.

Zolmitriptan stimulates a Ca(2+)-dependent K(+) current in C6 glioma cells stably expressing recombinant human 5-HT(1B) receptors.

Le Grand B, Panissié A, Perez M, Pauwels PJ, John GW.

Eur J Pharmacol. 2000 Jun 2;397(2-3):297-302.

PMID:
10844127
21.

Lubeluzole-induced prolongation of cardiac action potential in rabbit Purkinje fibres.

Le Grand B, Dordain-Maffre M, John GW.

Fundam Clin Pharmacol. 2000 Mar-Apr;14(2):159-62.

PMID:
10796064
22.
23.

F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.

John GW, Pauwels PJ, Perez M, Halazy S, Le Grand B, Verscheure Y, Valentin JP, Palmier C, Wurch T, Chopin P, Marien M, Kleven MS, Koek W, Assie MB, Carilla-Durand E, Tarayre JP, Colpaert FC.

J Pharmacol Exp Ther. 1999 Jul;290(1):83-95.

PMID:
10381763
24.

Present and future of 5-HT receptor agonists as antimigraine drugs.

Pauwels PJ, John GW.

Clin Neuropharmacol. 1999 May-Jun;22(3):123-36. Review.

PMID:
10367177
25.

Activation of recombinant h 5-HT1B and h 5-HT1D receptors stably expressed in C6 glioma cells produces increases in Ca2+-dependent K+ current.

Le Grand B, Panissié A, Pauwels PJ, John GW.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Dec;358(6):608-15.

PMID:
9879718
26.

Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist.

Perez M, Pauwels PJ, Fourrier C, Chopin P, Valentin JP, John GW, Marien M, Halazy S.

Bioorg Med Chem Lett. 1998 Mar 17;8(6):675-80.

PMID:
9871581
27.

Effects of sumatriptan on coronary flow and left ventricular function in the isolated perfused guinea pig heart.

Le Grand B, Vié B, John GW.

J Cardiovasc Pharmacol. 1998 Sep;32(3):435-42.

PMID:
9733357
28.

Late sodium current inhibition in human isolated cardiomyocytes by R 56865.

Le Grand B, Coulombe A, John GW.

J Cardiovasc Pharmacol. 1998 May;31(5):800-4.

PMID:
9593082
29.
30.

Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat.

Pagniez F, Valentin JP, Vieu S, Colpaert FC, John GW.

Br J Pharmacol. 1998 Jan;123(2):205-14.

31.
32.

Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.

Bertolino F, Valentin JP, Patoiseau JF, Rieu JP, Colpaert FC, John GW.

Naunyn Schmiedebergs Arch Pharmacol. 1997 Oct;356(4):462-6.

PMID:
9349632
33.

Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.

Valentin JP, Jover B, Maffre M, Bertolino F, Bessac AM, John GW.

Am J Hypertens. 1997 Sep;10(9 Pt 1):1058-63.

PMID:
9324114
34.

Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.

Valentin JP, Vieu S, Bertolino F, Fauré P, John GW.

J Pharmacol Exp Ther. 1997 Feb;280(2):761-9.

PMID:
9023289
35.

Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.

Valentin JP, Bessac AM, Maffre M, John GW.

Eur J Pharmacol. 1996 Dec 19;317(2-3):335-42.

PMID:
8997619
36.

Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonists.

Halazy S, Perez M, Fourrier C, Pallard I, Pauwels PJ, Palmier C, John GW, Valentin JP, Bonnafous R, Martinez J.

J Med Chem. 1996 Dec 6;39(25):4920-7.

PMID:
8960551
38.

HOE 694 affords protection versus veratrine contractures in rat atria by Na+ channel blockade.

Le Grand B, Marty A, Talmant JM, John GW.

Fundam Clin Pharmacol. 1996;10(5):467-73.

PMID:
8902550
39.

Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potential.

Le Grand B, Talmant JM, Rieu JP, Patoiseau JF, Colpaert FC, John GW.

J Cardiovasc Pharmacol. 1995 Nov;26(5):803-9.

PMID:
8637196
40.

Increased resistance to ischaemic injury in the isolated perfused atherosclerotic heart of the cholesterol-fed rabbit.

Le Grand B, Vié B, Fauré P, Degryse AD, Mouillard P, John GW.

Cardiovasc Res. 1995 Nov;30(5):689-96.

PMID:
8595614
41.

Synthesis and serotonergic activity of arylpiperazide derivatives of serotonin: potent agonists for 5-HT1D receptors.

Perez M, Fourrier C, Sigogneau I, Pauwels PJ, Palmier C, John GW, Valentin JP, Halazy S.

J Med Chem. 1995 Sep 1;38(18):3602-7.

PMID:
7658447
42.

Alleviation of contractile dysfunction in ischemic hearts by slowly inactivating Na+ current blockers.

Le Grand B, Vie B, Talmant JM, Coraboeuf E, John GW.

Am J Physiol. 1995 Aug;269(2 Pt 2):H533-40.

PMID:
7653617
43.

Use of the pithed rat model to determine the relative potencies of 5-HT2A/2C receptor antagonists following acute intravenous and oral administration.

Valentin JP, Bessac AM, Colpaert FC, John GW.

Methods Find Exp Clin Pharmacol. 1995 May;17(4):267-71.

PMID:
7475513
44.

TxA2 receptor activation elicits organ-specific increases in microvascular permeability in the rat.

Bertolino F, Valentin JP, Maffre M, Bessac AM, John GW.

Am J Physiol. 1995 Feb;268(2 Pt 2):R366-74.

PMID:
7864230
45.

Ketanserin inhibits the transient outward current in rabbit ventricular myocytes.

Le Grand B, Marty A, Colpaert FC, John GW.

J Cardiovasc Pharmacol. 1995 Feb;25(2):341-4.

PMID:
7752662
46.
47.

[Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog].

Bertolino F, Valentin JP, Maffre M, Jover B, Bessac AM, John GW.

Arch Mal Coeur Vaiss. 1994 Aug;87(8):971-4. French.

PMID:
7755474
49.

Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.

Bertolino F, Valentin JP, Maffre M, Jover B, Bessac AM, John GW.

J Pharmacol Exp Ther. 1994 Feb;268(2):747-52.

PMID:
8113986
50.

Veratrine-induced tetanic contracture of the rat isolated left atrium. Evidence for novel direct protective effects of prazosin and WB4101.

Le Grand B, Marty A, Vieu S, Talmant JM, John GW.

Naunyn Schmiedebergs Arch Pharmacol. 1993 Aug;348(2):184-90.

PMID:
7901775

Supplemental Content

Support Center